BMI May Affect CV, but Not Kidney, Benefits of GLP-1 Drugs

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become an important therapeutic option for type 2 diabetes, with potential cardiorenal benefits. However, benefits differ depending on the type of GLP-1 RA administered and patient…